Review of Pancreatic Lesions in Von Hippel-Lindau Disease
Journal Title: Archives of Clinical Gastroenterology - Year 2016, Vol 2, Issue 2
Abstract
Von Hippel-Lindaudisease (VHLD) is a rare hereditary tumor syndrome, inherited in autosomal dominant manner. Patients diagnosed with VHLD have a high risk of developing neoplasms of various organs (eyes, central nervous system, bone, kidney, adrenal glands, epididymis, broad ligament and pancreas). Due to its rarity, most of the physicians fail to properly diagnose it in time, and they might expose patients to a risk of unnecessary surgeries with important consequences in a long run. When this condition is diagnosed, lifelong follow-up is necessary. Pancreatic involvement it is seen in most patients with VHLD and various pancreatic lesions have been described, including cystic lesions (simple unilocular or serous microcystic or macro/micro-cystic adenomas), neuroendocrine tumors (NET), renal cell cancer metastasis and adenocarcinoma. These lesions are rarely the primary presenting tumor and frequently diagnosed during the screening of family members with VHLD, by imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT). Cystic lesions are the most common, generally asymptomatic and are rarely associated with malignant degeneration, except mucinous cysts. It is recommended follow-up and intervention if these lesions become symptomatic or mucinous aspect. NET are usually multiple, nonfunctional and have malignant potential. The management of NET depends on size, doubling time and underlying genetics. Because of their malignant potential, it is necessary careful observation in a long-term follow-up. If treatment is necessary, more conservative management is preferable. Molecular targets for treatment of NET in VHLD have also been proposed and some drugs are in preclinical or clinical trials.
Authors and Affiliations
Ferreira Gomes1 Tárcia Nogueira, de Almeida Costa Lívia, Lenz Luciano, de Sousa Giovana Biasia, Libera Ermelindo Della, Nakao Frank Shigueo
Keywords
Related Articles
- EP ID EP325490
- DOI 10.17352/2455-2283.000018
- Views 92
- Downloads 0
A Review on Therapeutic Management of Chronic Hepatitis B Infection
The current therapeutic goal in the management of chronic hepatitis B (CHB) infection is to persistently suppress hepatitis B virus (HBV) replication and prevent its progression to liver failure and the development of he...
Acute Pancreatitis, Actualization and Evidence Based Management
Acute pancreatitis (AP) is a systemic immunoinflammatory response to auto-digestion of the pancreas and peri-pancreatic organs. It is a frequent gastrointestinal disease with an important morbi-mortality, reaching 30% in...
Left Hepatectomy for Hepatocellular Carcinoma left liver with underlying cirrhosis and portal hypertension
Introduction: Hepatocellular carcinoma (HCC) is a major public health problem worldwide and is the second most common cause of cancer related deaths worldwide. If liver functional reserves and future liver remnant are ad...
Granulomatous Gastritis Associated with Sarcoidosis: Case Report
Granulomatous gastritis is a condition which may occur in association with Crohn’s disease, sarcoidosis, Wegener’s granulomatosis, tuberculosis, foreign body reaction or certain drugs including cocaine. Here, we report a...
Antiulcerogenic activity of species Annona coriacea Mart. and Spiranthera odoratissima A. St. Hil
Background: Medicinal plants from the Brazilian Cerrado are used in folk medicine to treat several diseases such as gastric disorders. Purpose: The present work evaluated the antiulcerogenic and antimicrobial effects of...